Advertisement
UK markets close in 5 hours 24 minutes

  • FTSE 100

    8,096.20
    +55.82 (+0.69%)
     

  • FTSE 250

    19,729.44
    +10.07 (+0.05%)
     

  • AIM

    755.17
    +0.48 (+0.06%)
     

  • GBP/EUR

    1.1661
    +0.0016 (+0.14%)
     

  • GBP/USD

    1.2511
    +0.0048 (+0.39%)
     

  • Bitcoin GBP

    51,075.93
    -2,029.26 (-3.82%)
     

  • CMC Crypto 200

    1,359.63
    -22.94 (-1.66%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.72
    -0.09 (-0.11%)
     

  • GOLD FUTURES

    2,336.80
    -1.60 (-0.07%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,991.14
    -97.56 (-0.54%)
     

  • CAC 40

    8,048.52
    -43.34 (-0.54%)
     
Stock:

Trending tickers

Microsoft, Google, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Hunan Hansen Pharmaceutical Co. Ltd. : Overvalued relative to peers, but may deserve another look

CapitalCube
Updated
Hunan Hansen Pharmaceutical Co. Ltd. : Overvalued relative to peers, but may deserve another look

Categories: Yahoo Finance Hunan Hansen Pharmaceutical Co. Ltd. relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 56. Our analysis is based on comparing Hunan Hansen Pharmaceutical Co. Ltd. with the following peers – Mayinglong Pharmaceutical Group Co., Ltd. Class A, Jiangsu Hengrui Medicine Co., Ltd. Class A, Jilin Zixin ... Read more (Read more...)

Continue reading